Gene therapy for hematological malignancies
Ozawa, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 8): 619-622
2010
ISSN/ISBN: 0047-1852 PMID: 20979309 Document Number: 646228
Document emailed within 1 workday
Related Documents
Usui, N. 2019: Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 859-861Kimura, N.; Kikuchi, M. 1989: Analysis of T-cell receptor delta chain gene in hematological malignancies Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 52(8): 1471-1478
Aderka, D.; Levo, Y. 1986: Interferon therapy in hematological malignancies Harefuah 110(8): 400-405
Resegotti, L. 1993: The therapy of hematological malignancies in the elderly Haematologica 78(3): 141-144
Ezaki, K. 1996: Cytokine therapy for hematological malignancies International Journal of Hematology 65(1): 17-29
Terui, Y. 2012: Monoclonal antibody therapy in hematological malignancies Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 217-221
Nagura, E.; Kawashima, K. 1986: Secondary malignancies associated with hematological malignancies following anticancer treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(4 Part 2): 1464-1474
Angelucci, E.; Polchi, P.; Lucarelli, G.; Galimberti, M.; Baronciani, D.; Giardini, C.; Durazzi, S.M.; Moretti, L.; Donati, M. 1989: Allogeneic bone marrow transplantation for hematological malignancies following therapy with high doses of busulphan and cyclophosphamide Haematologica 74(5): 455-461
Wierda, W.G.; Kipps, T.J. 2000: Gene therapy of hematologic malignancies Seminars in Oncology 27(5): 502-511
Okamura, S.; Ikematsu, W. 1993: Hematological malignancies with eosinophilia Nihon Rinsho. Japanese Journal of Clinical Medicine 51(3): 800-805
Takeshita, A.; Ohno, R. 2000: New combination therapies in hematological malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(3): 388-394
Jha, A. 2013: Spectrum of hematological malignancies and peripheral cytopenias Journal of Nepal Health Research Council 11(25): 273-278
Ishizawa, K. 2007: The standard treatments for patients with hematological malignancies in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(5): 709-712
Yoshida, T.; Nakanishi, J.; Ito, K.; Kobayashi, S.; Ohtake, S.; Nakamura, S.; Hattori, K. 1984: Phase Ii study of etoposide (NK 171) in advanced hematological malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(8): 1579-1584
Inazawa, J.; Abe, T. 1992: Applications of FISH to chromosome analysis in hematological malignancies Nihon Rinsho. Japanese Journal of Clinical Medicine 50(6): 1298-1303
Zhong, M.-z.; Chen, F.-p.; Shu, Y.-g. 2002: Hematopoietic stem cell transplantation for hematological malignancies Hunan Yi Ke da Xue Xue Bao 27(3): 242-244
Khodakova, I.A. 2014: Adjustment disorders in children, first hospitalized for hematological malignancies Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(9): 4-8
Drénou, B.; Fardel, O.; Fauchet, R.; Amiot, L. 2002: Flow cytometry: application for the diagnosis and the follow-up of hematological malignancies Annales de Biologie Clinique 60(6): 663-672
Masutani, H. 2000: Oxidative stress response and signaling in hematological malignancies and HIV infection International Journal of Hematology 71(1): 25-32
Sampi, K.; Honda, T.; Hayashi, Y.; Hattori, M. 1983: Phase Ii study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(6): 1538-1539